These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 20974918)

  • 1. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
    Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the polycomb protein EED in the propagation of repressive histone marks.
    Margueron R; Justin N; Ohno K; Sharpe ML; Son J; Drury WJ; Voigt P; Martin SR; Taylor WR; De Marco V; Pirrotta V; Reinberg D; Gamblin SJ
    Nature; 2009 Oct; 461(7265):762-7. PubMed ID: 19767730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.
    Montgomery ND; Yee D; Montgomery SA; Magnuson T
    J Mol Biol; 2007 Dec; 374(5):1145-57. PubMed ID: 17997413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methylation by PRC2 is inhibited by active chromatin marks.
    Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
    Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.
    Kuzmichev A; Nishioka K; Erdjument-Bromage H; Tempst P; Reinberg D
    Genes Dev; 2002 Nov; 16(22):2893-905. PubMed ID: 12435631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
    Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
    Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.
    Ueda T; Nakata Y; Nagamachi A; Yamasaki N; Kanai A; Sera Y; Sasaki M; Matsui H; Honda Z; Oda H; Wolff L; Inaba T; Honda H
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10370-5. PubMed ID: 27578866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.
    Wei Y; Chen YH; Li LY; Lang J; Yeh SP; Shi B; Yang CC; Yang JY; Lin CY; Lai CC; Hung MC
    Nat Cell Biol; 2011 Jan; 13(1):87-94. PubMed ID: 21131960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of EZH2 recognition by EED.
    Han Z; Xing X; Hu M; Zhang Y; Liu P; Chai J
    Structure; 2007 Oct; 15(10):1306-15. PubMed ID: 17937919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding.
    Kasinath V; Poepsel S; Nogales E
    Biochemistry; 2019 Feb; 58(5):346-354. PubMed ID: 30451485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
    Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
    Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
    Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
    Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
    O'Meara MM; Simon JA
    Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.
    Justin N; Zhang Y; Tarricone C; Martin SR; Chen S; Underwood E; De Marco V; Haire LF; Walker PA; Reinberg D; Wilson JR; Gamblin SJ
    Nat Commun; 2016 Apr; 7():11316. PubMed ID: 27121947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.
    Cao R; Wang L; Wang H; Xia L; Erdjument-Bromage H; Tempst P; Jones RS; Zhang Y
    Science; 2002 Nov; 298(5595):1039-43. PubMed ID: 12351676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
    Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
    Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance.
    Chu L; Tan D; Zhu M; Qu Y; Ma X; Song BL; Qi W
    J Biol Chem; 2023 Apr; 299(4):103073. PubMed ID: 36858198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.